Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and exporter, and ...

New findings from the RECOVER-Adult cohort study show that 25 routine clinical lab tests are not effective in diagnosing postacute sequelae of SARS-CoV-2 infection, echoing results from earlier ...

HAYWARD, Calif.--(BUSINESS WIRE)--The first diagnostic test for long COVID is now available to patients across Australia. The test can help physicians diagnose long COVID by differentiating it from ...

After running more than 160,000 tests for COVID-19, the UC Santa Cruz Colligan Clinical Diagnostic Laboratory will wind down its support of COVID-19 testing. With widespread COVID-19 testing available ...

NEW YORK, Aug. 12 (UPI) --Blood and urine tests are ineffective for diagnosing long COVID -- a constellation of long-term symptoms such as chronic pain, brain fog, shortness of breath and intense ...

In early February 2020, Kirsten St. George and her team at New York state's public health lab received a test developed by the Centers for Disease Control and Prevention to diagnose people infected ...

Microbix Biosystms ( ($TSE:MBX) ) has shared an update. Microbix Biosystems Inc. has partnered with SEKISUI Diagnostics to support the U.S.

PCR testing soared during the pandemic as the go-to, drive-through, quick-turnaround way to discover if you had COVID. The genie is out of the bottle. The worldwide market for PCR tests is predicted ...

WICHITA, Kan. (KSNW) — During the worst of the COVID-19 pandemic, local health officials came to rely on Wichita State University’s Molecular Diagnostics Laboratory (MDL). Now that the worst appears ...

Long Covid has long eluded scientists looking for its cause. Not knowing what triggers its persistent and distressing symptoms makes the condition challenging to treat; it’s hard to even say ...